Lung Cancer is the leading cause of death and also in many other countries around the world and is plaguing millions of people each year. Our treatment measures have proven our ability to induce remission of the disease and halting any further spreading through our advanced lung cancer treatment ...
期刊官网: http://www.journals.elsevier.com/lung-cancer/ 投稿链接: https://www.editorialmanager.com/LUNGCANCER 5 审稿周期 《Lung Cancer》官网审稿周期约63天(官方)。 6 版面费 根据官网显示《Lung Cancer》是一本接受开放获取的期刊,发表文章需要支付版面费USD$3200。 05 收录情况 《Lung Cancer》被3个...
Our oncology department is based in Bangkok and offers the latest innovations for the treatment of lung cancer. Lung Cancer is the leading cause of death in Thailand and also in many other countries around the world and is plaguing millions of people each year. Our treatment measures have prove...
Translational Lung Cancer Research provides practical up-to-date information on prevention, early detection, diagnosis, and treatment of lung cancer.
Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region. Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, ...
LUNG CANCER是一本专注于肺癌研究领域的学术期刊。该期刊旨在发表有关肺癌的原创研究、诊断、治疗策略、流行病学以及临床试验等方面的文章,为深入了解和应对肺癌提供科学支持。 1.期刊基本信息 研究方向:肺癌 出版周期:12 issues/year 出版年份:1985 出版国家:NETHERLANDS ...
官方网站 http://www.journals.elsevier.com/lung-cancer/ 投稿网站 http://ees.elsevier.com/lungcancer/default.asp?pg=preRegistration.asp 通讯地址 Elsevier Ireland Ltd, Elsevier House, Brookvale Plaza, East Park Shannon, Co, Clare, Ireland, 00000 所属国家 Netherlands 出版周期 Monthly 创办年份 1985...
根据官方信息,"Lung Cancer"期刊的审稿周期大约为25天 10.版面费 "Lung Cancer"期刊若选择OA的出版模式,需要支付文章处理费用:3110美元。 11.网址信息 期刊官网:https://www.journals.elsevier.com/lung-cancer 投稿网址:https://www.editorialmanager.com/lung/default.aspx ...
Lung CancerPubMedAJSCIE中科院2区JCR:Q2 发文量29,001 被引量229,321 影响因子(2023)1.758 Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region. Original research articles, early reports, review articles, editorial...
来源：药渡Daily 今日（12月11日），迪哲药业官网在其官网宣布，舒沃替尼（商品名舒沃哲®）单药治疗EGFR突变的非小细胞肺癌患者的临床I/II期研究的汇总分析最新数据发表于欧洲肿瘤内科学会（ESMO）官方期刊《Lung Cancer》，本次汇总分析涵盖WU-KONG1（NCT03974022)，WU-KONG2（CTR20192097）and WU-KONG15（...